Bayer, Janssen Pay $775M To End Xarelto Suits
Bayer and Janssen Pharmaceuticals announced a $775 million deal Monday to settle about 25,000 lawsuits alleging that the companies failed to warn about internal bleeding risks caused by blood thinner Xarelto....To view the full article, register now.
Already a subscriber? Click here to view full article